false
Catalog
Medication for Opioid Use Disorder (MOUD)
Slides
Slides
Back to course
Pdf Summary
The document provides an overview of Medicated Opioid Use Disorder (MOUD) and Medication Assisted Treatment (MAT), focusing on treatments for opioid use disorder (OUD) using medications like Methadone and Buprenorphine. MOUD utilizes medications to manage withdrawal symptoms and help treat OUD as a chronic condition, reducing stigma around medication use. MAT, although traditionally associated with alcohol addiction treatments like Naltrexone and Disulfiram, is now also applied to OUD, especially with studies advancing on medications like injectable Naltrexone (Vivitrol) for longer-term effectiveness.<br /><br />Key medications discussed include Methadone, noted for its effectiveness in reducing cravings and withdrawal without causing euphoria. It is ideal for individuals with significant opioid use histories or those who cannot tolerate other treatments. Buprenorphine, often combined with Naloxone, acts partially on opioid receptors to alleviate cravings and prevent withdrawal, with higher doses proving effective against medications like Fentanyl. Recent regulatory changes have expanded Buprenorphine prescription capabilities to practitioners, enhancing access to treatment.<br /><br />The document stresses the challenges posed by societal stigma, which can deter individuals from seeking MOUD or MAT. Common misconceptions include beliefs that these treatments are merely substituting one addiction for another and that they cause health problems. The stigma often leads to inadequate access to healthcare and treatment discrimination.<br /><br />The text concludes with notes on the importance of addressing stigma to ensure broader accessibility and effectiveness of addiction treatments, highlighting the importance of changing perceptions about OUD patients and the treatment options available to them. The document includes references to studies and guidelines shaping the current understanding and treatment approaches in addiction medicine.
Keywords
Medicated Opioid Use Disorder
Medication Assisted Treatment
Opioid Use Disorder
Methadone
Buprenorphine
Naltrexone
Stigma
Withdrawal Symptoms
Addiction Treatment
Regulatory Changes
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English